Detalhe da pesquisa
1.
A unique nanoparticulate TLR9 agonist enables a HA split vaccine to confer FcγR-mediated protection against heterologous lethal influenza virus infection.
Int Immunol
; 31(2): 81-90, 2019 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30535055
2.
An Antigen-Free, Plasmacytoid Dendritic Cell-Targeting Immunotherapy To Bolster Memory CD8+ T Cells in Nonhuman Primates.
J Immunol
; 200(6): 2067-2075, 2018 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29431693
3.
CD63-Mediated Antigen Delivery into Extracellular Vesicles via DNA Vaccination Results in Robust CD8+ T Cell Responses.
J Immunol
; 198(12): 4707-4715, 2017 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28507029
4.
Circulating tumor-associated antigen-specific IFNγ+4-1BB+ CD8+ T cells as peripheral biomarkers of treatment outcomes in patients with pancreatic cancer.
Front Immunol
; 15: 1363568, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38550601
5.
Humoral and cellular immune responses to COVID-19 mRNA vaccines in immunosuppressed liver transplant recipients.
Commun Med (Lond)
; 4(1): 30, 2024 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38409262
6.
Hepatitis B surface antigen reduction is associated with hepatitis B core-specific CD8+ T cell quality.
Front Immunol
; 14: 1257113, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37920475
7.
saRNA vaccine expressing membrane-anchored RBD elicits broad and durable immunity against SARS-CoV-2 variants of concern.
Nat Commun
; 14(1): 2810, 2023 05 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37208330
8.
Safety and immunogenicity of SARS-CoV-2 self-amplifying RNA vaccine expressing an anchored RBD: A randomized, observer-blind phase 1 study.
Cell Rep Med
; 4(8): 101134, 2023 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37586325
9.
Assessment of Fcγ receptor-dependent binding of influenza hemagglutinin vaccine-induced antibodies in a non-human primate model.
iScience
; 25(10): 105085, 2022 Oct 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36147947
10.
Functional changes in cytotoxic CD8+ T-cell cross-reactivity against the SARS-CoV-2 Omicron variant after mRNA vaccination.
Front Immunol
; 13: 1081047, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36685601